https://www.selleckchem.com/ALK.html
PEA-m also reduced the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κ spinal pathway, showing a protective effect in a rat model of PO. The results obtained reinforce the idea that PEA-m may be a potential treatment for the control of pain and inflammatory processes associated with PO. In addition, pre- and post-treatment with PEA-m is more effective than treatment alone after the surgery and this limits the time of taking the compound and the abuse of analgesics. The results obtained reinforce the idea that PEA-m may be a po

https://www.selleckchem.com/pr....oducts/sirpiglenasta
Iatrogenic vascular occlusion secondary to filler injection, such as with hyaluronic acid, is a known but rare, entity. It typically occurs in the setting of facial cosmetic procedures but has also been described in the setting of osteoarthritis. We present a patient with ankle osteoarthritis who developed an asymmetric, reticular, livedoid eruption after intraarticular injection with hyaluronic acid. She was diagnosed with livedo racemosa secondary to vascular occlusion and placed on low molecular weight heparin. Later, a transi